Antares Pharma, Inc. (ATRS) said Tuesday that it has closed its firm commitment underwritten public offering of 12.5 million shares of the company's common stock at a purchase price of $4.00 per share.
The net proceeds to the company are expected to be about $46.7 million, after deducting underwriting commissions and estimated offering expenses payable by the company.
Jefferies & Company, Inc. and Oppenheimer and Co. Inc. acted as joint book-running managers for the offering. Cowen and Company, LLC and Ladenburg Thalmann & Co. Inc. acted as co-managers for the offering.
For comments and feedback: editorial@rttnews.com